COYA
Income statement / Annual
Last year (2024), Coya Therapeutics, Inc.'s total revenue was $3.55 M,
a decrease of 40.79% from the previous year.
In 2024, Coya Therapeutics, Inc.'s net income was -$14.88 M.
See Coya Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$3.55 M |
$6.00 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$11.87 M
|
$5.50 M
|
$4.41 M
|
$0.00
|
$0.00
|
| Gross Profit |
-$8.31 M
|
$500.68 K
|
-$4.41 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
-2.34
|
0.08
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.89 M
|
$6.04 M
|
$4.94 M
|
$2.54 M
|
$373.45 K
|
| General & Administrative Expenses |
$8.89 M
|
$7.83 M
|
$4.85 M
|
$2.31 M
|
$668.70 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.89 M
|
$7.83 M
|
$4.85 M
|
$2.31 M
|
$668.70 K
|
| Other Expenses |
-$11.84 M
|
-$5.47 M
|
-$4.39 M
|
$16.13 K
|
$0.00
|
| Operating Expenses |
$8.94 M
|
$8.40 M
|
$5.40 M
|
$4.87 M
|
$1.04 M
|
| Cost And Expenses |
$20.80 M
|
$13.91 M
|
$9.81 M
|
$4.87 M
|
$1.04 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$38.98 K
|
| Depreciation & Amortization |
$27.36 K
|
$27.36 K
|
$27.36 K
|
$16.13 K
|
$704.65 K
|
| EBITDA |
-$17.20 M |
-$7.33 M |
-$9.26 M |
-$4.85 M |
$0.00 |
| EBITDA Ratio |
-4.84
|
-1.22
|
0
|
0
|
0
|
| Operating Income Ratio |
-4.85
|
-1.32
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.65 M
|
$639.37 K
|
-$2.43 M
|
-$21.48 K
|
-$57.64 K
|
| Income Before Tax |
-$15.60 M
|
-$7.26 M
|
-$12.24 M
|
-$4.89 M
|
-$1.10 M
|
| Income Before Tax Ratio |
-4.39
|
-1.21
|
0
|
0
|
0
|
| Income Tax Expense |
-$720.29 K
|
$723.85 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$14.88 M
|
-$7.99 M
|
-$12.24 M
|
-$4.89 M
|
-$1.10 M
|
| Net Income Ratio |
-4.19
|
-1.33
|
0
|
0
|
0
|
| EPS |
-0.98 |
-0.79 |
-1.2309 |
-0.74 |
-0.42 |
| EPS Diluted |
-0.98 |
-0.79 |
-1.2309 |
-0.74 |
-0.42 |
| Weighted Average Shares Out |
$15.24 M
|
$10.16 M
|
$9.95 M
|
$6.60 M
|
$2.59 M
|
| Weighted Average Shares Out Diluted |
$15.24 M
|
$10.16 M
|
$9.95 M
|
$6.60 M
|
$2.59 M
|
| Link |
|
|
|
|
|
